Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen

NCT04191343 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Advanced Biliary Tract Tumors

Interventions

DRUG: Toripalimab injection combined with GEMOX

Sponsor

Zhejiang Cancer Hospital